BioLineRx (BLRX) Prepaid Assets (2011 - 2025)

BioLineRx's (BLRX) quarterly Prepaid Assets came in at $201000.0 in Q4 2025, down 54.63% year-on-year from $443000.0 in Q4 2024, and down 53.47% quarter-over-quarter from $432000.0 in Q3 2025.

BioLineRx (BLRX) Prepaid Assets (2011 - 2025) Analysis & Trends

BioLineRx's Prepaid Assets history runs 15 years deep, the most recent figure standing at $201000.0 for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 54.63% year-over-year to $201000.0 in Q4 2025; TTM through Dec 2025 was $201000.0, a 54.63% decrease from a year earlier, with the FY2025 full-year figure at $201000.0, down 54.63% from the prior year.
  • Prepaid Assets retreated to $201000.0 in Q4 2025 per BLRX's latest filing, from $432000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $1.7 million in Q2 2023 and bottomed at $127000.0 in Q4 2021.
  • The 5-year median for Prepaid Assets is $644500.0 (2022), against an average of $740600.0.
  • Across the five-year window, Prepaid Assets slumped 85.08% in 2022 and jumped 429.29% in 2023, its largest moves.
  • Year by year, Prepaid Assets stood at $127000.0 in 2021, then jumped by 55.91% to $198000.0 in 2022, then soared by 429.29% to $1.0 million in 2023, then plunged by 57.73% to $443000.0 in 2024, then tumbled by 54.63% to $201000.0 in 2025.
  • Per Business Quant, the three latest BLRX Prepaid Assets figures stand at $201000.0 (Q4 2025), $432000.0 (Q3 2025), and $572000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 BioLineRx 7.05 Bn 7.06 Bn 154,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 201,000.00
Sep 30, 2025 432,000.00
Jun 30, 2025 572,000.00
Mar 31, 2025 312,000.00
Dec 31, 2024 443,000.00
Sep 30, 2024 1.17 Mn
Jun 30, 2024 1.58 Mn
Mar 31, 2024 1.29 Mn
Dec 31, 2023 1.05 Mn
Sep 30, 2023 1.17 Mn
Jun 30, 2023 1.75 Mn
Mar 31, 2023 738,000.00
Dec 31, 2022 198,000.00
Sep 30, 2022 537,000.00
Jun 30, 2022 717,000.00
Mar 31, 2022 161,000.00
Dec 31, 2021 127,000.00
Sep 30, 2021 449,000.00
Jun 30, 2021 837,000.00
Mar 31, 2021 1.08 Mn